Cargando…

Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule Dynamics

Transglutaminase activity, arising potentially from transglutaminase 2 (TG2) and Factor XIIIA (FXIIIA), has been linked to osteoblast differentiation where it is required for type I collagen and fibronectin matrix deposition. In this study we have used an irreversible TG-inhibitor to ‘block –and-tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Jallad, Hadil F., Myneni, Vamsee D., Piercy-Kotb, Sarah A., Chabot, Nicolas, Mulani, Amina, Keillor, Jeffrey W., Kaartinen, Mari T.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024320/ https://www.ncbi.nlm.nih.gov/pubmed/21283799 http://dx.doi.org/10.1371/journal.pone.0015893

Ejemplares similares

Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase
por: Gates, Eric W. J., et al.
Publicado: (2023)

Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet
por: Myneni, Vamsee D., et al.
Publicado: (2016)

Transglutaminase 2—a novel inhibitor of adipogenesis
por: Myneni, V D, et al.
Publicado: (2015)

Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018)

Ethacrynic acid is an inhibitor of human factor XIIIa
por: Kar, Srabani, et al.
Publicado: (2022)

Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
por: Ebrahimi Samani, Sahar, et al.
Publicado: (2023)

A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
por: Kim, Soo-Youl, et al.
Publicado: (2020)

Tissue immunostaining for factor XIIIa in dermal dendrocytes of pityriasis alba skin lesions()
por: Carneiro, Francisca Regina Oliveira, et al.
Publicado: (2014)

Mass Spectrometric Identification of a Novel Factor XIIIa Cross-Linking Site in Fibrinogen
por: Semkova, Mariya E., et al.
Publicado: (2021)

Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers
por: K, Kavithamani, et al.
Publicado: (2023)

Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells
por: Caron, Nicholas S., et al.
Publicado: (2012)

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
por: Gates, Eric W. J., et al.
Publicado: (2023)

Design of a glutamine substrate tag enabling protein labelling mediated by Bacillus subtilis transglutaminase
por: Oteng-Pabi, Samuel K., et al.
Publicado: (2018)

Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity
por: Kreutz, Rolf P., et al.
Publicado: (2018)

Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
por: Arati, S., et al.
Publicado: (2019)

Non-invasive in vivo imaging of acute thrombosis: development of a novel factor XIIIa radiotracer
por: Andrews, Jack P M, et al.
Publicado: (2020)

Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
por: De Simone, Ilaria, et al.
Publicado: (2022)

Transglutaminases and Obesity in Humans: Association of F13A1 to Adipocyte Hypertrophy and Adipose Tissue Immune Response
por: Kaartinen, Mari T., et al.
Publicado: (2020)

Allosteric Activation of Transglutaminase 2 via Inducing an “Open” Conformation for Osteoblast Differentiation
por: Yang, Zhuo, et al.
Publicado: (2023)

Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
por: Fisher, Matthew L., et al.
Publicado: (2015)

Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile
por: Al-Horani, Rami A., et al.
Publicado: (2016)

Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
por: Porrello, Alessandro, et al.
Publicado: (2018)

Prognostic Value of TRPM7 Expression and Factor XIIIa-Expressing Tumor-Associated Macrophages in Gastric Cancer
por: Calik, Muhammet, et al.
Publicado: (2021)

Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation
por: Colak, Gozde, et al.
Publicado: (2011)

Secretion of Streptomyces mobaraensis pro-transglutaminase by coryneform bacteria
por: Itaya, Hiroshi, et al.
Publicado: (2008)

Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation
por: Adhikary, Gautam, et al.
Publicado: (2018)

Mast cell–derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections
por: Piliponsky, Adrian M., et al.
Publicado: (2022)

Influence of substrate curvature on osteoblast orientation and extracellular matrix deposition
por: Pilia, Marcello, et al.
Publicado: (2013)

Active secretion of a thermostable transglutaminase variant in Escherichia coli
por: Wang, Xinglong, et al.
Publicado: (2022)

Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa
por: Sheffield, William P, et al.
Publicado: (2011)

Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
por: Palaçon, Mariana Paravani, et al.
Publicado: (2023)

Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury
por: Elahi, Anissa, et al.
Publicado: (2021)

Differences in Steady-State Erythropoiesis in Different Mouse Bones and Postnatal Spleen
por: Myneni, Vamsee D., et al.
Publicado: (2021)

The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2
por: Bianchi, Nicoletta, et al.
Publicado: (2021)

Fibulin-4 deposition requires EMILIN-1 in the extracellular matrix of osteoblasts
por: Schiavinato, Alvise, et al.
Publicado: (2017)

Tissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line
por: Yin, Xiaoxue, et al.
Publicado: (2012)

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits
por: Stenman, Satumarja M, et al.
Publicado: (2008)

Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2
por: Jambrovics, Károly, et al.
Publicado: (2020)

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer
por: Aguiari, Gianluca, et al.
Publicado: (2022)

Comprehensive Review of Adipose Stem Cells and Their Implication in Distraction Osteogenesis and Bone Regeneration
por: Morcos, Mina W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bkqcde34ag2sb4jrrpvkk929bc